WHO ICTRP trial

A Prospective, Observational Study of Men With Premature Ejaculation Who Are…

EUCTR2009-011309-18-FI · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2009-011309-18-FI
Public title A Prospective, Observational Study of Men With Premature Ejaculation Who Are Treated With PRILIGY™ or Alternate Care - PAUSE
Scientific title A Prospective, Observational Study of Men With Premature Ejaculation Who Are Treated With PRILIGY™ or Alternate Care - PAUSE
Primary sponsor Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Finland
Conditions premature ejaculation MedDRA version: 12.0 Level: PT Classification code 10036596 Term: Premature ejaculation
Interventions Trade Name: Priligy Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Dapoxetine Hydrochloride CAS Number: 119356773 Current Sponsor code: R096769 Concentration unit: mg milligram(s) Concentration type: equal Concentration…
Registration date Jun 11, 2009
Target size 12000
Secondary IDs R096769PRE4001
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations